# Neptune Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neptune-medical

- Industry: Medical Devices & Equipment
- Headquarters: York, UK
- Website: www.neptunemedical.co.uk/
- Total disclosed funding: $97M
- Latest round: Series D (Aug 15, 2024)
- Investors on record: 2

## About

Founded in 2019 and based in York, UK, Neptune Medical Limited specialzies in supplying orthopedic and bone regeneration products to enhance surgical outcomes and patient care for NHS and private hospitals. In August 2024, Neptune Medical Limited raised USD 97 million in Series D funding from Sonder Capital and Olympus Corporation.

The company’s product portfolio includes a range of specialized orthopedic solutions and bone regeneration technologies. The firm distributes Bonalive Bioactive Glass, which is a product known for its osteostimulative properties that are crucial for bone regeneration, filling, and reconstruction. Bonalive Bioactive Glass supports in ENT, orthopedic, spine, and cranio-maxillofacial surgeries. In addition, Neptune Medical collaborates with NCS to distribute the GT Tunneler. The company also partners with LEDA Orthopaedics, a provider of orthopedic products, and Corin, a global innovator in orthopedic technology. These partnerships allow Neptune Medical to offer a range of products designed to meet the needs of healthcare professionals.

The organization plans to use the August 2024 funding for new product innovation and development.

## Funding rounds

- Series D, Aug 15, 2024, $97M — Olympus Corporation, Sonder Capital

## Investors

- Olympus Corporation — Series D
- Sonder Capital (https://capitalatlas.ai/funds/sonder-capital) — Series D